BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7290939)

  • 1. [Cefsulodine concentrations in cerebral ventricles during parenteral treatment of ventriculitis due to Pseudomonas aeruginosa (author's transl)].
    Veyssier P; Dusehu E
    Nouv Presse Med; 1981 Oct; 10(35):2881-2. PubMed ID: 7290939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)].
    Segura C; Foz A; Fuster C; Tirado M; Roy C
    Med Clin (Barc); 1981 Jun; 77(2):50-5. PubMed ID: 6798336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Pseudomonas infections in children with cefsulodin (author's transl)].
    Rosenkranz A
    Wien Med Wochenschr; 1981 Oct; 131(20):511-4. PubMed ID: 7314634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriological studies in vitro on cefsulodin, a new cephalosporin active against Pseudomonas (author's transl)].
    Grimm H
    Arzneimittelforschung; 1980; 30(9):1478-80. PubMed ID: 7193011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical application of cefsulodin to Pseudomonas aeruginosa infections in the surgical field (author's transl)].
    Tanimura H; Mukaihara S; Hikasa Y; Hajiro A; Takenada M; Maki Y; Nakajima K; Henmi K; Nio Y; Kikuchi S; Hamagaki H; Sugimoto S; Kobayashi M; Matsukawa Y; Masuda K; Yasumoto H; Usui H
    Jpn J Antibiot; 1981 Apr; 34(4):459-65. PubMed ID: 7289036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory and clinical studies on cefsulodin (author's transl)].
    Kumasaka Y; Nakahata H; Endo K; Sasaki K; Matsuhashi A; Narita S; Imamura K; Takebe K; Masaki N; Tamura T
    Jpn J Antibiot; 1981 Oct; 34(10):1416-21. PubMed ID: 6460884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefsulodin in the treatment of Pseudomonas meningitis].
    Brückner O; Collmann H; Trautmann M
    Infection; 1983; 11(5):264-8. PubMed ID: 6642678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of cefsulodin in the field of pediatrics].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Nakazawa S; Chikaoka H; Tazoe K
    Jpn J Antibiot; 1982 Nov; 35(11):2633-8. PubMed ID: 7169663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of cefsulodin for the infection caused by P. aeruginosa in otorhinolaryngological field].
    Sugita R; Kawamura S; Fujimaki Y; Deguchi K
    Jpn J Antibiot; 1982 Dec; 35(12):2825-30. PubMed ID: 7182536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies of cefsulodin in the pediatric field].
    Minamitani M; Hachimori K; Suzuki M
    Jpn J Antibiot; 1982 Nov; 35(11):2676-82. PubMed ID: 7169666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome.
    Yagmur R; Esen F
    Crit Care; 2006; 10(6):428. PubMed ID: 17214907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topical administration of cefsulodin in postoperative Pseudomonas aeruginosa infection of the middle ears].
    Oda M; Futaki T
    Jpn J Antibiot; 1983 Sep; 36(9):2494-6. PubMed ID: 6655864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of cefsulodin on Pseudomonas aeruginosa infections in otorhinolaryngology].
    Makishima K; Nakashima T; Toriya Y; Murata Y; Watanabe H; Kannae S
    Jpn J Antibiot; 1982 Dec; 35(12):2835-8. PubMed ID: 7182538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and reversible nephrotoxicity of cefsulodin during treatment of septicemia from Pseudomonas aeruginosa infection of a pacemaker].
    Penalba C; Girard PM; Cremieux AC; Michelet C; Saimot AG; Kernbaum S
    Ann Med Interne (Paris); 1984; 135(7):519-22. PubMed ID: 6517423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic and clinical evaluation on cefsulodin in the field of obstetrics and gynecology].
    Takase Z; Ichinohe K; Kutsuzawa T; Yamada Y; Yorozu Y; Domon H; Kodama M; Matsuda S; Cho N; Fukunaga K; Kunii K; Wagatsuma T; Tabei T; Kaku R; Hanaoka S; Hogaki M; Muronosono E; Shiojima Y; Sumiyoshi Y; Osada H; Kusaba N; Hayashi S; Nakamura H; Goto T; Ihara Y; Hagiwara K; Tsuruta S; Endo K; Fukae T; Yabuki A; Noda K; Hayasaki M; Iwasa S; Hasegawa Y; Ninomiya K; Ohbayashi F; Yamada F; Seiga K; Hirabayashi K; Doko F; Kohlita Y; Yamabe T; Motomura R; Kubota K; Deguchi K; Fugono T; Mizuta E
    Jpn J Antibiot; 1982 Dec; 35(12):2861-77. PubMed ID: 6820668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of cefsulodin in the field of pediatrics].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Nov; 35(11):2688-98. PubMed ID: 6820394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.